How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

28 June 2021
At the roundtable, HIV stakeholders identified areas where HIV Outcomes might be able to contribute to the ongoing work around the health-related quality of (HRQoL) of people living with HIV ...
More
23 June 2021
At the satellite symposium, scientific experts, policymakers and patient representatives will provide different perspectives on the long-term impact of COVID-19 and HIV/AIDS on the health-related quality of life of ...
More
22 June 2021
In view of the upcoming EU4Health's first call for projects, the Secretariat organised a Working Group Session with the Steering Group and General Members to learn priority areas for ...
More
Filters
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.